Antifungal resistance is a rising public health threat and a lesser-known aspect of the antimicrobial resistance crisis. There is a growing need for alternative treatments as current therapies lose effectiveness. Even in agriculture, resistant fungal species require the application of harmful pesticides, further emphasizing the need for innovative and eco-friendly solutions to this concern. At Bioadvance, our main focus is on researching and developing bioactive molecules to effectively combat fungal diseases. We are dedicated to creating safer antifungal agents to address the growing challenge of drug resistance, while also supporting sustainable solutions for crop protection.
Company Details
- Founded
- -
- Address
- The Growing Challenge Of Drug Resistance
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Bioadvance Questions
Bioadvance's LinkedIn profile is https://www.linkedin.com/company/bioadvance-rd
Bioadvance's industry is
Biotechnology Research
Bioadvance's categories are Biotechnology Research
Bioadvance's founding year is 2022
